Chinook Therapeutics Inc. (KDNY)
NASDAQ: KDNY
· Real-Time Price · USD
40.39
0.09 (0.22%)
At close: Aug 10, 2023, 10:00 PM
Chinook Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 1.01M | 1.83M | 512K | 2.5M | 418K | 2.7M | 51.24M | 4K | 34K | 351K |
Cost of Revenue | 433K | 433K | 429K | 431K | 429K | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 575K | 1.4M | 83K | 2.07M | -11K | 2.7M | 51.24M | 4K | 34K | 351K |
Operating Income | -72.63M | -61.42M | -59.91M | -57.68M | -36.69M | -30.81M | 12.39M | -31.01M | -43.27M | -37.15M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -68.96M | -58.32M | -57.46M | -55.99M | -35.92M | -30.91M | 12.39M | -31.07M | -43.31M | -37.22M |
Net Income | -66.94M | -60.18M | -61.8M | -54.29M | -37.65M | -31.68M | 7.54M | -30.7M | -42.57M | -37.22M |
Selling & General & Admin | 12.99M | 11.4M | 9.77M | 10.02M | 8.63M | 7.87M | 7.74M | 6.85M | 7.77M | 9.54M |
Research & Development | 57.9M | 50.88M | 42.95M | 41.98M | 30.02M | 26.25M | 24.93M | 23.57M | 22.79M | 25.7M |
Other Expenses | n/a | 433K | 433K | 431K | 429K | -95K | 5K | -69K | -39K | -67K |
Operating Expenses | 71.39M | 62.72M | 53.15M | 52.44M | 39.09M | 34.55M | 33.09M | 30.84M | 30.98M | 35.66M |
Interest Expense | n/a | n/a | 4.82M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 71.39M | 62.72M | 53.15M | 52.44M | 39.09M | 34.55M | 33.09M | 30.84M | 30.98M | 35.66M |
Income Tax Expense | -2.01M | 1.86M | 4.34M | -1.7M | 1.73M | -263K | 3.3M | -463K | -741K | n/a |
Shares Outstanding (Basic) | 71.59M | 70.7M | 69.22M | 67.78M | 61.98M | 58.34M | 51.67M | 44.66M | 43.86M | 42.14M |
Shares Outstanding (Diluted) | 71.59M | 70.7M | 69.22M | 67.78M | 61.98M | 58.34M | 53.69M | 44.66M | 43.86M | 42.14M |
EPS (Basic) | -0.94 | -0.85 | -0.89 | -0.8 | -0.61 | -0.54 | 0.15 | -0.69 | -0.97 | -0.88 |
EPS (Diluted) | -0.94 | -0.85 | -0.89 | -0.8 | -0.61 | -0.54 | 0.14 | -0.69 | -0.97 | -0.88 |
EBITDA | -69.9M | -63.03M | -47.38M | -40.93M | -39.39M | -31.59M | 24.32M | -29.56M | -17.44M | -32.25M |
EBIT | n/a | -63.47M | -52.64M | -57.68M | -36.69M | n/a | n/a | n/a | n/a | n/a |
Depreciation & Amortization | 1.91M | -1.62M | 12.52M | 16.75M | -2.7M | 1.29M | 422K | 1.11M | 1.17M | 1.22M |